Haleos Labs (NSE:HALEOSLABS) EPS (Basic): ₹57.27 (TTM As of Mar. 2026)


NSE:HALEOSLABS Haleos Labs Ltd NSE:HALEOSLABS
70 GF Score
Price ₹1,399.40
GF Value ₹1,122.97
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Haleos Labs EPS (Basic)?

Haleos Labs NSE:HALEOSLABS +2.06% 70 EPS (Basic) is ₹57.27 as of Mar. 2026. GuruFocus rates NSE:HALEOSLABS with a GF Score™ of 70/100 and a GF Value™ of ₹1,122.97 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Haleos Labs's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹1.44. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹57.27.

Haleos Labs's EPS (Diluted) for the three months ended in Mar. 2026 was ₹1.44. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹57.27.

Haleos Labs's EPS without NRI for the three months ended in Mar. 2026 was ₹1.44. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 57.27.

During the past 12 months, Haleos Labs's average EPS without NRIGrowth Rate was -13.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was 23.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 6.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 11 years, Haleos Labs's highest 3-Year average EPS without NRI Growth Rate was 27.60% per year. The lowest was -12.40% per year. And the median was -3.10% per year.

Haleos Labs  (NSE:HALEOSLABS) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Haleos Labs EPS (Basic) Related Terms

Haleos Labs EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Haleos Labs's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haleos Labs EPS (Basic) Chart

Haleos Labs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 83.76 37.92 30.08 66.51 57.26

Haleos Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.83 13.75 20.19 21.89 1.44
NSE:HALEOSLABS
70GF Score
Haleos Labs Ltd NSE:HALEOSLABS
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Haleos Labs EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Haleos Labs's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(173.12-0)/3.023
=57.27

Haleos Labs's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(4.357-0)/3.026
=1.44

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹57.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹57.27 mean?
Haleos Labs (NSE:HALEOSLABS) has a EPS (Basic) of ₹57.27 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Haleos Labs and its competitors.
Is Haleos Labs' EPS (Basic) too high?
Haleos Labs' current EPS (Basic) is ₹57.27. Overall, Haleos Labs has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Haleos Labs' EPS (Basic) compare to VRTX and REGN?
Haleos Labs' EPS (Basic) of ₹57.27 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Haleos Labs and its competitors. Haleos Labs's current EPS (Basic) is ₹57.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haleos Labs stock overvalued right now?
Based on GuruFocus' analysis, Haleos Labs (NSE:HALEOSLABS) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,122.97, compared to a current price of ₹1,399.40 — trading 24.6% above its estimated fair value. The current EPS (Basic) is ₹57.27. Haleos Labs' overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Haleos Labs (NSE:HALEOSLABS), the current EPS (Basic) is ₹57.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Haleos Labs (NSE:HALEOSLABS) Overvalued in 2026?

Based on GuruFocus' analysis, Haleos Labs stock appears to be overvalued. The current stock price of ₹1,399.40 is trading 24.6% above its estimated GF Value™ of ₹1,122.97. GuruFocus considers Haleos Labs to be Modestly Overvalued.

Key valuation signals for NSE:HALEOSLABS:

  • EPS (Basic): ₹57.27
  • GF Value™: ₹1,122.97 vs. price of ₹1,399.40 (24.6% above fair value)
  • GF Score™: 70/100 with 5 warning signs

No single metric tells the full story. See the NSE:HALEOSLABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Haleos Labs Business Description

Other Exchanges 540679:India
Address Road Number 71, Plot Number 19 - III, Opposite Bharatiya Vidya Bhavan Public School, Jubilee Hills, Hyderabad, TG, IND, 500096
Haleos Labs Ltd is engaged in the Business of manufacturing Active Pharmaceutical Ingredients (APIs) and its intermediates and sells its products in India as well as exports. The group sells its products in India and also exports it to other countries. Some of its API products are used in therapy as an Antiulcer, Antifungal, Anti Obesity, Anesthesia, and others. The company has manufacturing facilities at Kazipally and Jeedimetla and its Research and Development center at Sanatnagar in Hyderabad.
70GF Score

Get the complete analysis for NSE:HALEOSLABS

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,399.40
Price
₹1,122.97
GF Value